Our findings provide strong evidence for the distinct clinical impacts and biological functions of ANGPT/ANGPTL proteins in BC development and progression, suggesting that some of them, such as ANGPTL1 and 4, could be potential therapeutic targets for BCs. This evidence concerns the gene ANGPTL1 and breast cancer.